skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
AC-T Regimen (Code C63427)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: AC-T Regimen

Definition: A chemotherapy regimen consisting of doxorubucin hydrochloride (Adriamycin) and cyclophosphamide, followed by paclitaxel (Taxol), administered on either a dose-dense or sequential schedule and used as an adjuvant treatment for breast cancer.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol).

Label: AC-T Regimen

NCI Thesaurus Code: C63427 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1879500  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
AC-Taxol Regimen
AC-Taxol regimen
AC-T Regimen
AC-T regimen

External Source Codes: 
PDQ Closed Trial Search ID 631444
PDQ Open Trial Search ID 631444 (check for NCI PDQ open clinical trial info)
UMLS CUI C1879500

Other Properties:
     Name Value (qualifiers indented underneath)
code C63427
DesignNote Source: NCCN Guidelines 2007
Legacy_Concept_Name AC-T_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom